Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Dana-Farber Cancer Institute (DFCI) is seeking a Pre-Clinical Imaging Technologist to support the cancer research activities at the Lurie Family Imaging Center (LFIC). The LFIC is a state-of-the-art 14,000-square foot preclinical imaging facility, equipped with preclinical in vivo imaging capabilities, including Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT), Computed Tomography (CT), Ultrasound Imaging (US), Optical Imaging (BLI/ FLI), and image-guided radiation therapy, in order to support investigators with their research programs and studies using innovative and relevant imaging strategies. The interdisciplinary in vivo translational and experimental therapeutics studies conducted at the LFIC are focused on cancer, with an emphasis on in vivo pharmacology and the assessment of novel cancer therapeutics, multimodality imaging of cancer, molecular imaging of pharmacodynamic efficacy, development of novel imaging probes, and target validation. For more information please visit: http://www.lfic.dfci.harvard.edu/
The Pre-Clinical Imaging Technologist will integrate with a highly skilled team of preclinical Technologists and Scientists, and report directly to the LFIC Director. He/ she will execute in-vivo imaging mouse studies, as well as the entire spectrum of conventional (e.g., caliper measurements, clinical scoring) endpoints to evaluate experimental cancer therapeutics. He/ she must be able to work in a team environment, contribute intellectually and technically to the setting, and work in compliance with the local, state, federal and regulations and guidelines.
Mon-Fri, some nights and weekends will be required.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.